Investors who over-weigh their portfolios with blue-chip tech stocks have done really well in recent years. However, looking ahead, there's another investment that should be on investors' radar. Read More

As third-quarter corporate scorecards start pouring in this week, the real news for investors is international expansion, not monetary and fiscal policy in the U.S. Read More

Marijuana stocks are all the rage, as investors fixate on the growth potential of legalized weed. Here’s a small-cap biotech that’s disrupting the pot as well as tobacco industries. Read More

My “three-legged stool” analytical approach is one of the best tools there is for predicting the market’s next move, and it doesn't look good going into October 20th options expiration. Read More

One of the surest ways to reap rapid profits is to invest in entrepreneurial drug makers that target unmet needs. We highlight enticing small-cap plays that are ready to soar. Read More

This week, Obamacare is proving to be untouchable yet again. While lawmakers get zapped trying to replace it, you can make money. Read More

As with all investments, acquiring the yellow metal involves the right timing and the right choices. Here’s how to gain exposure to bullion, without the bull. Read More

As hurricanes Jose and Maria barrel eastward in the wake of Harvey and Irma, history shows that hurricanes significantly lift the markets in general and certain high-yield plays in particular.   Read More

With severe storms and climate change dominating the news, solar power takes center stage as a technology and an investment. Read More

The devastation wrought by hurricanes Harvey and Irma on agriculture and energy production is a boon for commodity plays that can provide growth as well as income. Read More